{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:22:15Z","timestamp":1775701335247,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Massachusetts General Hospital Department of Oral and Maxillofacial Surgery Education and Research Fund"},{"name":"Center for Applied Clinical Investigation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijom.2019.04.014","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T08:17:22Z","timestamp":1557735442000},"page":"1289-1299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Genetic predisposition for medication-related osteonecrosis of the jaws: a systematic review"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9774-7175","authenticated-orcid":false,"given":"J.","family":"Sandro Pereira da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pullano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.S.","family":"Raje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Troulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"August","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2019.04.014_bib0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.04.014_bib0010","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.04.014_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2019.04.014_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1348-8643(12)00045-6","article-title":"Pathophysiology of BRONJ: drug-related osteoclastic disease of the jaw","volume":"10","author":"Ikebe","year":"2013","journal-title":"Oral Sci Int"},{"key":"10.1016\/j.ijom.2019.04.014_bib0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.coms.2015.06.003","article-title":"The frequency of medication-related osteonecrosis of the jaw and its associated risk factors","volume":"27","author":"Dodson","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ijom.2019.04.014_bib0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fon.13.211","article-title":"Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents","volume":"10","author":"Campisi","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijom.2019.04.014_bib0035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.joms.2007.03.006","article-title":"Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy","volume":"65","author":"Wang","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.04.014_bib0040","first-page":"3817","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies","volume":"33","author":"Assaf","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijom.2019.04.014_bib0045","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1248\/bpb.b15-00385","article-title":"Incidence and risk factors of osteonecrosis of the jaw in advanced cancer patients after treatment with zoledronic acid or denosumab: a retrospective cohort study","volume":"38","author":"Kajizono","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijom.2019.04.014_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.surge.2011.09.002","article-title":"Bisphosphonate osteonecrosis of the jaw: a historical and contemporary review","volume":"10","author":"McLeod","year":"2012","journal-title":"Surgeon"},{"key":"10.1016\/j.ijom.2019.04.014_bib0055","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/SCS.0000000000002564","article-title":"Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis?","volume":"27","author":"Giovannacci","year":"2016","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.ijom.2019.04.014_bib0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.mehy.2011.11.011","article-title":"Is oral bisphosphonate-related osteonecrosis of the jaw an endemic condition?","volume":"78","author":"Diz","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ijom.2019.04.014_bib0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ctrv.2015.04.007","article-title":"Drug induced osteonecrosis of the jaw","volume":"41","author":"Hamadeh","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijom.2019.04.014_bib0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.coms.2015.06.005","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"27","author":"Fung","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ijom.2019.04.014_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8768162","article-title":"Medication-related osteonecrosis of the jaw: new insights into molecular mechanisms and cellular therapeutic approaches","volume":"2016","author":"Lombard","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.ijom.2019.04.014_bib0080","unstructured":"Genetics Home Reference: Genomic research. Lister Hill National Center for Biomedical Communications, US National Library of Medicine, National Institutes of Health, Department of Health and Human Services, July 17, 2018."},{"key":"10.1016\/j.ijom.2019.04.014_bib0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.urology.2018.06.033","article-title":"Polymorphisms of PTH (parathyroid hormone) gene and risk of kidney stone disease: a case\u2013control study from West Bengal, India","volume":"121","author":"Mitra","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.ijom.2019.04.014_bib0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.21037\/atm.2018.04.11","article-title":"Alzheimer\u2019s disease neuroimaging initiative: the impact of GAB2 genetic variations on cerebrospinal fluid markers in Alzheimer\u2019s disease","volume":"6","author":"Chen","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijom.2019.04.014_bib0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5114\/ada.2018.76226","article-title":"ERAP1 and HLA-C*06 are strongly associated with the risk of psoriasis in the population of northern Poland","volume":"35","author":"Stawczyk-Macieja","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.ijom.2019.04.014_bib0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/apm.12855","article-title":"Evaluation of TLR2, TLR4, and TOLLIP polymorphisms for their role in tuberculosis susceptibility","volume":"126","author":"Wu","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.ijom.2019.04.014_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Altman DG; the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijom.2019.04.014_bib0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jech.44.3.179","article-title":"Bias in case\u2013control studies: a review","volume":"44","author":"Kopec","year":"1990","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.ijom.2019.04.014_bib0115","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijom.2019.04.014_bib0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ijom.2019.04.014_bib0125","first-page":"579","article-title":"A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer","volume":"6","author":"English","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ijom.2019.04.014_bib0130","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3324\/haematol.2011.042572","article-title":"CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ijom.2019.04.014_bib0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1601-0825.2012.01912.x","article-title":"New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw","volume":"18","author":"Balla","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2019.04.014_bib0140","doi-asserted-by":"crossref","first-page":"e 0118084","DOI":"10.1371\/journal.pone.0118084","article-title":"Genetic investigation of bisphosphonate-related osteonecrosis of the jaw (BRONJ) via whole exome sequencing and bioinformatics","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijom.2019.04.014_bib0145","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.2147\/OTT.S88463","article-title":"Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma","volume":"8","author":"Sun","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ijom.2019.04.014_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jbmr.3285","article-title":"SIRT1\/HERC4 locus associated with bisphosphonate-induced osteonecrosis of the jaw: an exome-wide association analysis","volume":"33","author":"Yang","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2019.04.014_bib0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijom.2011.02.002","article-title":"Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw","volume":"40","author":"Katz","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.04.014_bib0160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0714.2010.01004.x","article-title":"Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws","volume":"40","author":"Arduino","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijom.2019.04.014_bib0165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2141.2011.08622.x","article-title":"A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling","volume":"154","author":"Di Martino","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijom.2019.04.014_bib0170","first-page":"364","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"3","author":"Marini","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.ijom.2019.04.014_bib0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/bmm.12.14","article-title":"An aromatase polymorphism (g.132810C>T) predicts risk of bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"La Ferla","year":"2012","journal-title":"Biomark Med"},{"key":"10.1016\/j.ijom.2019.04.014_bib0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcms.2012.10.018","article-title":"Major histocompatibility complex II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw","volume":"41","author":"Stockmann","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijom.2019.04.014_bib0185","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/odi.12355","article-title":"Genetic association between VEGF polymorphisms and BRONJ in the Korean population","volume":"21","author":"Choi","year":"2015","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2019.04.014_bib0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0022034514560768","article-title":"Diabetes as a risk factor for medication-related osteonecrosis of the jaw","volume":"94","author":"Peer","year":"2015","journal-title":"J Dent Res"},{"key":"10.1016\/j.ijom.2019.04.014_bib0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra0905980","article-title":"Genomewide association studies and assessment of the risk of disease","volume":"363","author":"Manolio","year":"2010","journal-title":"N Engl J Med"},{"issue":"R2","key":"10.1016\/j.ijom.2019.04.014_bib0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/ddn287","article-title":"Genome-wide association studies in cancer","volume":"17","author":"Easton","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ijom.2019.04.014_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002822","article-title":"Chapter 11: genome-wide association studies","volume":"8","author":"Bush","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ijom.2019.04.014_bib0210","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.0306-5251.2001.01510.x","article-title":"Candidate gene case\u2013control association studies: advantages and potential pitfalls","volume":"52","author":"Daly","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijom.2019.04.014_bib0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000342120","article-title":"Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis","volume":"129","author":"Zhong","year":"2013","journal-title":"Acta Haematol"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502719311117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502719311117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:31:01Z","timestamp":1760272261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502719311117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0901502719311117"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2019.04.014","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition for medication-related osteonecrosis of the jaws: a systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2019.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of International Association of Oral and Maxillofacial Surgeons.","name":"copyright","label":"Copyright"}]}}